We also performed differential methylation analysis comparing the genetic alteration status, specifically looking at BRAF fusion status (n = 12) and then grouped BRAF fusion and BRAFV600E status (n = 17) of the tumours (Additional file 3: Supplementary Methods). This evidence concerns the gene BRAF and neoplasm.